Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
90,256,578
-
Share change
-
+6,358,108
-
Total reported value
-
$443,198,769
-
Put/Call ratio
-
46%
-
Price per share
-
$4.91
-
Number of holders
-
110
-
Value change
-
+$31,862,065
-
Number of buys
-
58
-
Number of sells
-
45
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2017
As of 31 Dec 2017,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,256,578 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, Vanguard Group Inc, GREAT POINT PARTNERS LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and RTW INVESTMENTS, LP.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.